Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laird, Peter W."'
Autor:
Tsou, Jeffrey A, Galler, Janice S, Siegmund, Kimberly D, Laird, Peter W, Turla, Sally, Cozen, Wendy, Hagen, Jeffrey A, Koss, Michael N, Laird-Offringa, Ite A
Publikováno v:
Molecular Cancer; 2007, Vol. 6, p70-82, 13p
Autor:
Laird PW; Van Andel Institute, Grand Rapids, MI 49503, USA.
Publikováno v:
Epigenomics [Epigenomics] 2022 Mar; Vol. 14 (6), pp. 303-308. Date of Electronic Publication: 2022 Mar 24.
Autor:
Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Staudt L; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Takebe N; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., O'Sullivan-Coyne G; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Kohn E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Mann B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Jacobs PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Berryman SM; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Bowen J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Leraas K; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Shen H; Van Andel Research Institute, Grand Rapids, MI, USA., Laird PW; Van Andel Research Institute, Grand Rapids, MI, USA., Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain., Miller V; Foundation Medicine Inc, Cambridge, MA, USA., Johnson A; Foundation Medicine Inc, Cambridge, MA, USA., Edmondson EF; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Giordano TJ; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 27-37.
Autor:
Huo D; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois; Center for Clinical Cancer Genetics, Department of Medicine, The University of Chicago, Chicago, Illinois, Hu H; Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, Pennsylvania, Rhie SK; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, Gamazon ER; Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee, Cherniack AD; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, Liu J; Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, Pennsylvania, Yoshimatsu TF; Center for Clinical Cancer Genetics, Department of Medicine, The University of Chicago, Chicago, Illinois, Pitt JJ; Committee of Genetics, Genomics, and Systems Biology, The University of Chicago, Chicago, Illinois, Hoadley KA; Department of Genetics and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Troester M; Department of Epidemiology, The University of North Carolina at Chapel Hill, Ru Y; Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, Pennsylvania, Lichtenberg T; The Research Institute, Nationwide Children’s Hospital, Columbus, Ohio, Sturtz LA; Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, Pennsylvania, Shelley CS; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Benz CC; Buck Institute for Research on Aging, Novato, California, Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Laird PW; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan, Shriver CD; Clinical Breast Care Project, Murtha Cancer Center, Walter Reed National Military Medical Center/Uniformed Services University of the Health Sciences, Bethesda, Maryland, Perou CM; Department of Genetics and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Olopade OI; Center for Clinical Cancer Genetics, Department of Medicine, The University of Chicago, Chicago, Illinois; Committee of Genetics, Genomics, and Systems Biology, The University of Chicago, Chicago, Illinois
Publikováno v:
JAMA oncology [JAMA Oncol] 2017 Dec 01; Vol. 3 (12), pp. 1654-1662.
Autor:
Beck S; Research Department of Cancer Biology, University College London Cancer Institute, University College London, London, United Kingdom., Bernstein BE, Campbell RM, Costello JF, Dhanak D, Ecker JR, Greally JM, Issa JP, Laird PW, Polyak K, Tycko B, Jones PA
Publikováno v:
Cancer research [Cancer Res] 2012 Dec 15; Vol. 72 (24), pp. 6319-24. Date of Electronic Publication: 2012 Nov 27.
Autor:
Laird PW; University of Southern California, Keck School of Medicine, USC Epigenome Center, 1450 Biggy Street, Los Angeles, CA 90089-99601, USA. plaird@usc.edu
Publikováno v:
Epigenomics [Epigenomics] 2009 Oct; Vol. 1 (1), pp. 29-31.